1. Home
  2. BRUN vs PSNL Comparison

BRUN vs PSNL Comparison

Compare BRUN & PSNL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Boost Run Inc. Class A Common Stock

BRUN

Boost Run Inc. Class A Common Stock

N/A

Current Price

$19.21

Market Cap

1.4B

Sector

Technology

ML Signal

N/A

Logo Personalis Inc.

PSNL

Personalis Inc.

HOLD

Current Price

$18.38

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
BRUN
PSNL
Founded
N/A
2011
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Medical Specialities
Sector
Technology
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.4B
IPO Year
2026
2019

Fundamental Metrics

Financial Performance
Metric
BRUN
PSNL
Price
$19.21
$18.38
Analyst Decision
Strong Buy
Analyst Count
0
5
Target Price
N/A
$12.20
AVG Volume (30 Days)
2.3M
3.2M
Earning Date
N/A
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
33.58
EPS
N/A
N/A
Revenue
N/A
$69,648,000.00
Revenue This Year
N/A
$15.34
Revenue Next Year
N/A
$41.46
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$15.58
$4.65
52 Week High
$40.46
$17.06

Technical Indicators

Market Signals
Indicator
BRUN
PSNL
Relative Strength Index (RSI) 42.03 77.01
Support Level $16.34 $7.52
Resistance Level $22.75 N/A
Average True Range (ATR) 2.22 0.77
MACD 0.38 0.39
Stochastic Oscillator 22.96 90.03

Price Performance

Historical Comparison
BRUN
PSNL

About BRUN Boost Run Inc. Class A Common Stock

Boost Run Inc is an NVIDIA Cloud Provider. Its platform provides GPU compute, CPU nodes, managed Kubernetes orchestration, and shared storage through an intuitive management console and a robust API layer, enabling organizations to provision and scale resources across thousands of nodes in minutes. Enterprises rely on Boost Run to power their main demanding AI workloads with the performance, security, and reliability their operations require. The group maintains SOC 2 Type II, HIPAA, ISO 27001, and ISO 27701 certifications at the operator level, and partners with data center facilities that uphold equivalent security and compliance standards.

About PSNL Personalis Inc.

Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. The company' products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.

Share on Social Networks: